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To simulate and monitor the evolution of posttraumatic sepsis in mice, we combined a two-hit model of trauma/hemorrhage
(TH) followed by polymicrobial sepsis with repetitive blood sampling. Anesthetized mice underwent femur fracture/sublethal
hemorrhage and cecal ligation and puncture (CLP) 48h later. To monitor outcome-dependent changes in circulating
cells/biomarkers, mice were sampled daily (facial vein) for 7 days and retrospectively divided into either dead (DIE) or surviving
(SUR) by post-CLP day 7. Prior to CLP, AST was 3-fold higher in DIE, while all other post-TH changes were similar between
groups. There was a signiﬁcant post-CLP intergroup separation. In SUR, RBC and Hb were lower, platelets and neutrophils
higher, and lymphocytes mixed compared to DIE. In DIE, all organ function markers except glucose (decrease) were few folds
higher compared to SUR. In summary, the combination of daily monitoring with an adequate two-hit model simulates the ICU
setting, allows insight into outcome-based responses, and can identify biomarkers indicative of death in the acute posttraumatic
sepsis in mice.
1.Introduction
With more than 751.000 cases per annum in USA [1]a n da n
incidence ranging from 0.4 to 1 case/1000 people in Europe
[2], sepsis is the leading cause of death in noncoronary
intensive care units [3]. Sepsis is routinely described as
the body’s systemic response to an invading pathogen
such as bacteria and/or fungus [4]. The current consensus
implies that early (acute) septic deaths have been associated
with an excessive exacerbation of the proinﬂammatory
immune response (termed systemic inﬂammatory response
syndrome or SIRS), which is then followed by the com-
pensatory anti-inﬂammatory response syndrome (CARS),
although biomarkers typical to either of those syndromes
may be released simultaneously [5, 6]. Systemic spread of
pathogens can originate from numerous organs/systems of
the body—the lung representing the most frequent site of
infection (68%), followed by the abdomen (22%), blood
(20%), and urinary tract (14%) [7].
The pathophysiology of sepsis is further complicated
by a variety of invading microorganisms, and that sepsis
typically occurs as a secondary complication (second hit).
Epidemiological data are inconsistent on the incidence of
post-traumatic sepsis: existing studies demonstrated that
post-injury sepsis/severe sepsis incidence ranges from 2%
to over 30% [8–10]. Furthermore, it has been corroborated
that trauma patients with sepsis have signiﬁcantly higher
ICU admission rates and mortality than their non-septic
counterparts, mostly due to the development of multiple
organ dysfunction syndrome (MODS) [10, 11].
Animal models are the launch platform to study the
pathophysiology of sepsis and septic shock since they feature2 Journal of Biomedicine and Biotechnology
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Figure 1: Schematic of the two-hit model and repetitive blood
sampling. 3-month-old female mice were subjected to trauma and
hemorrhage (TH) followed by polymicrobial CLP-induced sepsis.
Time span of model was divided into a pre-and post-CLP phase.
StartingatTH, a 20µL bloodsamplewascollected daily(until post-
TH day 7 post-CLP/day 5) from each animal, including one extra
sample at 6h after-CLP.
a maximally controlled milieu and optimal experimental
reproducibility [12, 13]. Over the past decades, the most
widely used approach has typically employed a bolusadmin-
istration of live/inactivated bacteria and their components
such as lipopolysaccharide (LPS). While acute intravenous
infusion of LPS/endotoxin is essentially inadequate for
recapitulation of protracted septic events [14, 15], the cecal
ligation and puncture (CLP) and colon ascendens stent peri-
tonitis (CASP) models, although not ideal, appear to be the
best existing alternative for emulating human polymicrobial
sepsis to date [16, 17]. Despite their wide use, all of the
above-mentionedmodelsmirrorprimary sepsisinducedbya
single challenge (one hit). To date, only a few animal models
attempted to recapitulate another, more clinically relevant
scenario of the two-hit challenge, in which sepsis develops
shortly after a survivable traumatic event. An early two-
hit model consisting of an initial hemorrhage followed by
a subsequent polymicrobial sepsis (CLP) in the mouse [18]
was developed by Stephan and collaborators. This approach
wasfurtherexpandedbyVanGriensvenetal.,who combined
partially lethal hemorrhage and nonlethal trauma as the ﬁrst
hit and applied CLP as the subsequent hit [19]. A diﬀerent
two-hit approach, developed to investigate the evolution of
nosocomial lung infections after abdominal sepsis in the
mouse, features CLP (as the ﬁrst hit) followed by a single-
strain bacterial pneumonia [20–22].
The multiorigin epidemiology of sepsis and dynamic
alterations of its responses emphasize that successful treat-
ment of sepsis should rely on highly individualized ther-
apeutic interventions [23]. We have recently shown that
dexamethasonetreatment administered tohomogenoussub-
groups of mice (stratiﬁed based on predicted outcome)
markedly improved the survival of those mice with severe
sepsisbutconferred no beneﬁtonthemoderately sickcohort
[24]. Such a targeted approach requires preclinical modeling
that suﬃciently reproduces both multistep pathophysiology
of a given septic complication and the standard ICU
monitoring protocol. Therefore, we combined the modiﬁed
two-hit sepsis model (unilateral femur fracture/sublethal
hemorrhage followed by CLP) with our recently validated
daily blood-based monitoring method. Next, we tested this
design by surveying the evolution of exemplary immunolog-
ical, organ function, and metabolic alterations prior to and
after intraabdominal sepsis. Speciﬁcally, diﬀerences between
dying and surviving animals during both hit phases were
investigated.
2.Materialsand Methods
2.1. Animals. 3 - m o n t h - o l d ,f e m a l eC D - 1m i c e( t o t a ln =
120) with an average weight of 30g were used for all
experiments. Mice were purchased fromHarlanLaboratories
(Udine, Italy) and were kept in groups of ﬁve per cage
on a 12h light-dark cycle. Temperature was maintained
between 22–24◦C, and standard rodent diet and water were
provided ad libitum to all mice throughout the experiments.
All animal procedures were approved by the local legislative
committee and conducted according to National Institute of
Health guidelines.
2.2. Two-Hit Model. We modiﬁed the original two-hit
trauma/hemorrhage protocol developed by van Griensven
et al. [19]. In brief, the ﬁrst hit consisted of a noncom-
minuted, unilateral, midshaft femur fracture followed by
a hemorrhage via retro-orbital puncture (Figure 1). Femur
fracture was produced by custom-designed blunt pliers and
conﬁrmed by X-ray. For hemorrhage, total blood volume
(TBV) was calculated as 6% of total body weight and both
50% and 40% of TBV were tested to achieve survival of at
least 95% at the end (0h) of the posttrauma/hemorrhage
(TH) phase. After-TH, mice were resuscitated with 0.9%
sodium chloride subcutaneously, (NaCl) with four times the
volumeofshedblood:1mLcontaininganalgesia(0.05mg/kg
buprenorphine, Temgesic) was administered immediately
after hemorrhage (aimed toreproducethephase ofrestricted
resuscitation), while the remaining volume was given 1h
later (aimed to reproduce the phase of unrestricted resusci-
tation).
To induce the second hit, mice were subjected to CLP
48h after-TH (Figure 1). We followed the original CLP
protocol by Wichterman et al. [25]w i t han u m b e ro f
modiﬁcationsspeciﬁedelsewhere [26,27].Inordertoreceive
an approximate mortality of 50% at post-CLP day 5 (post-
TH day 7), diﬀerent grade of CLP severity was induced
by increasing needle sizes (i.e., 20, 19, 18, or 17 gauge
(G)). Starting with TH, mice were resuscitated twice daily
(excluding the immediate posthemorrhage resuscitation)
with 1ml of 0.9% NaCl including analgesia (0.05mg/kg
buprenorphine, Temgesic). From 2h after-CLP onward,
everymousewasresuscitated twicedailyfor5dayswith 1mL
Ringer solution containing analgesia (as above) and wide-
range antibiotic (25mg/kg imipenem, Zienam) to emulate
the “Surviving Sepsis Campaign Guidelines for Management
of Severe Sepsis and Septic Shock” [28]. For all surgical
procedures,micewere anesthetized withisoﬂurane (Forane),
and survival was monitored for seven days after TH.Journal of Biomedicine and Biotechnology 3
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Figure 2: 7-day mortality in 3-month-old female mice subjected to the two-hit model of trauma/hemorrhage followed by polymicrobial
CLP-induced sepsis. To achieve approximately 50% mortality at post-TH day 7 (50% hemorrhage of total blood volume, TBV), the severity
of CLP was adjusted by diﬀerent gauge needles (20G n = 10, 19G n = 10, 18G n = 10, 17G n = 22). To reach sublethality after hemorrhage,
∗P<. 05 between 50 and 40% blood loss group (of TBV) was tested with a 17-gauge needle (40% + 17G n = 65; 50% + 17G n = 16).
Given the aim of the experiment, sham surgeries were not
performed to reduce the total number of mice in the study.
2.3. Blood Sampling. Beginning immediately prior to hem-
orrhage (−48h time-point), 20µL of blood was collected via
facial vein puncture from each animal every 24h (including
an additional sample at 6h post-CLP) until post-CLP day
5 as previously described by Weixelbaumer et al. [29]
(Figure 1).Allsampleswereimmediatelydiluted1:10inPBS
with EDTA (diluted 1:50). After centrifugation (1g, 5min,
22◦C), 180µL of plasma was removed and stored at −80◦C
for further analysis.
2.4. Complete Blood Count. After removing plasma, the
remaining blood pellet was resuspended with 180µL Cell-
Dynbuﬀerwith EDTA prior to complete blood count (CBC)
analysis with a Cell Dyn 3700 counter (Abbott Laboratories,
Ill, USA).
2.5. Metabolic and Organ Function Parameters. Urea nitro-
gen (urea), glucose, lactate dehydrogenase (LDH), alanin
transaminase (ALT), and aspartate transaminase (AST) were
analyzedinplasmasampleswithaCobasc111reader(Roche,
Switzerland).
2.6. Statistical Analysis. Survival curves were plotted using
Kaplan-Meier method. Data were tested for normality, and
forallfurtheranalyses,micewereretrospectivelydividedinto
either surviving (SUR, alive by post-CLP day 5) or dying
(DIE, died between post-CLP day 1 and 5). Due to the high
variability and low n = 3 at 96h (post-CLP day 5) in the DIE
group, we excluded this time point from all graphs/analyses.
Regardless of whether pre-CLP (Figures 3–5)o rp o s t - C L P4 Journal of Biomedicine and Biotechnology
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Figure 3: Retrospective comparisonof red blood cell, platelet count, and hemoglobin concentration in dying (DIE) versus surviving (SUR)
animals prior to CLP. 3-month-old female mice were subjected to trauma/hemorrhage prior to CLP. Displayed values were compared
between DIE and SUR at −48h (DIE at least n = 17, SUR at least n = 18), −24h (DIE at least n = 28, SUR n = 32), 0h before-CLP
(DIE at least n = 28, SUR n = 32 for all parameters) and between time points. Dots represent outlayers. §P<. 05 between time points, and
∗P<. 05 between DIE and SUR.
(Figures 6–8), SUR versus DIE diﬀerences (each time point
separately) were evaluated by either Student’s t-test (nor-
mally distributed data) or Mann-Whitney test (abnormally
distributed data). One-way ANOVA followed by Dunn’s test
was used to assess longitudinal ﬂuctuations of all parameters
in the pre-CLP phase. All pre-CLP data (Figures 3–5)a r e
presented as Tukey box-plot diagram, while post-CLP data
are plotted as mean ± SEM (Figures 6–8). Statistical tests
were carried out using Prism 5 (GraphPad Software Inc.,
San Diego, USA), and the level of signiﬁcance was deﬁned
at P<. 05.
3.Results
3.1. Survival. The initial goal was to reach an overall mor-
tality of approximately 50% at the end of the acute phase
of sepsis (post-CLP day 5, post-TH day 7). All mice
were subjected to trauma (unilateral femur fracture) and
hemorrhage (50% of TBV) followed by CLP of varying
severity 48h later (Figure 2(a)). Hemorrhage of 50% of TBV
resulted in an average mortality of 27% at post-TH day 2.
CLP surgery with 17G needle produced additional mortality
of 34% leading to the overall mortality of approx. 60%
at post-CLP day 5 (post-TH day 7). CLP with remaining
needles was either mildly lethal (10% by 19G) or nonlethal
(20 and 18G) (Figure 2(a)). To eliminate the excessive loss
of mice induced by TH, we reduced the hemorrhage volume
to 40% of TBV. This signiﬁcantly lowered the post-TH
mortality from 27% to 4% (Figure 2(b)). All post-TH deaths
occurred within 1h of the hit.
Next,wetestedwhetherthechangeintheamountofshed
blood (50% versus 40%) aﬀected the post-CLP outcome.Journal of Biomedicine and Biotechnology 5
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Figure 4: Retrospective comparison of neutrophil and lymphocyte count in dying (DIE) versus. surviving (SUR) animals prior to CLP.
3-month-old female mice were subjected to trauma/hemorrhage prior to CLP. Displayed values were compared between DIE and SUR at
−48h (DIE n = 17, SUR n = 18), −24h (DIE n = 29, SUR n = 32) 0h before-CLP (DIE n = 31, SUR n = 34) and between time points.
Dots represent outlayers. §P<. 05 between time points.
Mice were subjected to TH with either 50% or 40% of TBV
followed by CLP with 17G needle (Figure 2(c)). The (post-
CLP) day-5 mortality was virtually identical for both groups
(56% versus 54%) (Figure 2(c)).
3.2. Pre-CLP (Post-TH) Phase
3.2.1. Red Blood Cells, Hemoglobin, and Platelets. In all sub-
sequent experiments, all mice were consistently subjected
to TH with 40% of TBV and CLP with 17G needle and
retrospectively divided into either SUR or DIE for further
comparisons (see Section 2.6).
TH hit caused a virtually identicalreduction ofred blood
cell (RBC) counts (by approximately 32%) and hemoglobin
(Hb) concentration (by approx. 31%) in both SUR and DIE
animals at −24h (Figures 3(a) and 3(b)), and the magnitude
of this decrease remained virtually unchanged until CLP (0h
time point).
Prior to TH (−48h time point), platelets (PLT) were
lower in SUR by approximately 11% (P<. 05) compared
to DIE mice (Figure 3(c)). At −24h, PLT insigniﬁcantly
decreased in SUR (by 13%) and in DIE (by 20%) animals
(compared to the respective counts at −48h). At 0h, PLT
recovered to their initial pre-TH values (both groups) with
the SUR PLT count approx. 10% lower (P<. 05) than in DIE
mice.
3.2.2. White Blood Cells. We investigated the eﬀect oftrauma
and hemorrhage on neutrophil (NEU) and lymphocyte
(LYM) population. TH hit did not aﬀect circulating leuko-
cytes (data not shown). Interestingly, while TH did not have
an immediate eﬀect upon circulating NEU, its delayed surge
(identical in both groups) was evident immediately prior to
CLP(0hversus−48hand −24h,P<. 05)(Figure 4(a)).Nei-
therlongitudinalnorintergroupdiﬀerenceswereobservedin
post-TH circulating LYM counts (Figure 4(b)).
3.2.3. Organ Function Parameters. TH hit caused a virtually
identical hypoglycemia in both SUR and DIE animals, as
evidenced by the approx. 40% drop of circulating glucose at
−24h (Figure 5(a)). Glucose remained low (approx. 70% of
the −48h value) in both (SUR and DIE) groups until CLP
(0h).
There was a strong AST spike in all mice at −24h
(Figure 5(b)), and this increase was 3-fold higher in DIE
compared to SUR mice (192.7versus 578.7U/L, P<. 05).
However, there was no signiﬁcant intergroup diﬀerence at
0h, as AST nearly recovered both in SUR (122U/L) and
DIE (172U/L) mice (Figure 5(b)). In ALT, there was also a
signiﬁcant post-TH increase at −24h, butin contrast toAST,
its magnitude (average 48%) was similar in both SUR and
DIE mice (Figure 5(c)).
The same was true for LDH: an initial 64% post-TH
surge at −24h (identical in SUR and DIE) was followed
by its marked recovery at 0h (Figure 5(d)). Levels of urea
diﬀered slightly (12%, P<. 05) between DIE and SUR prior
toTH(−48h,Figure 5(e)),butthisdissimilarity disappeared
at later (post-TH) time points (−24h and 0h).
3.3. Post-CLP Phase
3.3.1. Red Blood Cells, Hemoglobin, and Platelets. Regardless
of outcome, RBC counts and Hb concentration remained
decreased throughout the entire post-CLP period. In DIE
mice, RBC and Hb were slightly (but consistently) elevated
(e.g., 15% and 13% at 6h) compared to SUR. Sepsis caused
an almost identical PLT drop in both SUR and DIE groups6 Journal of Biomedicine and Biotechnology
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Figure 5: Retrospective comparison of circulating glucose, AST, ALT, LDH, and urea in dying (DIE) versus surviving (SUR) animals prior
to CLP. 3-month-old female mice were subjected to trauma/hemorrhage prior to CLP. Displayed values were compared between DIE and
SUR at −48h (DIE n = 16, SUR n = 18; AST: DIE n = 6, SUR n = 12), −24h (DIE n = 23, SUR n = 32; AST: SUR n = 21), 0h before-CLP
(DIE n = 23, SUR n = 32; AST: DIE n = 8, SUR n = 21) and between time points. §P<. 05 between time points, and ∗P<. 05 between DIE
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Figure 6: Retrospective comparison of red blood cell platelet count, and hemoglobin concentration in dying (DIE) versus surviving
(SUR) animals after-CLP. 3-month-old female mice were subjected to trauma/hemorrhage followed by polymicrobial CLP-induced sepsis.
Displayed values were compared between DIE and SUR group 6h (DIE at least n = 30, SUR at least n = 32), 24h (DIE at least n = 28, SUR
atleast n = 31), 48h (DIE atleast n = 16, SUR atleast n = 31), 72h (DIE at least n = 11, SUR at leastn = 32),and 96h (SUR atleast n = 26
for all parameters) after-CLP. Dotted lines represent normal values. ∗P<. 05.
until 48h post-CLP. Thereafter, PLTs began to recover in
SUR mice (further decline in DIE), reaching approx 80% of
baseline at 96h. A 2-fold separation between SUR and DIE
mice was recorded at 72h (Figure 6(c)).
3.3.2. White Blood Cells. Within the ﬁrst 48h, CLP resulted
in a drop of NEU in all mice with NEU counts typically
lower (e.g., by 31% at 24h and 21% at 72h) in DIE animals
comparedtoSUR(Figure 7(a)).From48honward,therewas
a gradual recovery of NEU, which at 72h either reached (in
DIE) or exceeded (in SUR) baseline values.
Similar to NEU, there was a rapid LYM decrease in all
mice within the ﬁrst 48h of CLP, with initial LYM counts
signiﬁcantly higher (by 17% at 6h and 51% at 24h) in
DIE compared to SUR (Figure 7(b)). This was followed by
a prominent shift between the SUR versus DIE groups: while
the 72h LYM count remained depressed in DIE mice, there
was a robust LYM recovery in SUR from 48h onward. At
72h, the SUR LYM count was higher by 40% (P<. 05)
(compared to the LYM count in DIE) and continued to
increase toward baseline (approx. 84% of the lower baseline
range at 96h) (Figure 7(b)).
3.3.3. Organ Function Parameters. Regardless of the group,
preexisting(post-TH)hypoglycemiaworsenedaftertheCLP-
induced sepsis. Compared to DIE, a slight glucose recovery
inSURmice wasnoted from48honward (byapprox.20%at
48hand 23%at72h,P<. 05)(Figure 8(a)).InbothDIEand8 Journal of Biomedicine and Biotechnology
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Figure 7: Retrospective comparison of neutrophil and lymphocyte count in dying (DIE) versus surviving (SUR) animals after-CLP. 3-
month-old female mice were subjected to trauma/hemorrhage followed by polymicrobial CLP-induced sepsis. Displayed values were
compared between DIE and SUR groups 6h (DIE n = 31, SUR n = 33), 24h (DIE n = 29, SUR n = 34), 48h (DIE n = 18, SUR
n = 32), 72h (DIE n = 12, SUR n = 32), and 96h (SUR n = 28) after-CLP. Dotted lines represent normal values. ∗P<. 05.
SUR groups, there was a notable post-CLP increase in AST.
The peak inter-group diﬀerence (DIE 2-fold higher than
SUR) was recorded at 48h (P<. 05) but disappeared at 72h
(Figure 8(b)). Such an intergroup separation was even more
pronounced in ALT: while its activity continuously increased
in DIEfrom 6h onward, it was gradually declining (transient
peak at 24h) in SUR reaching baseline by 96h (Figure 8(c)).
The maximal, 6-fold diﬀerence in circulating ALT between
SUR and DIE mice was recorded at 72h (0.3-fold at 24h and
4-fold at 48h).
Similar after-CLP response was observed for LDH and
urea. Both parameters were elevated in DIE mice: urea by
0.3-fold at 6h and by 3.6-fold between 24–72h, while LDH
by approximately 2-fold at 24h, 5-fold at 48h, and 3.5-fold
at 72h time point (P<. 05) compared to SUR. In SUR mice,
both urea and LDH values approached baseline from 48h
onward.
4.Discussion
The primary goal of our study was to reproduce a scenario,
in which an initial traumatic/hypovolemic event survived
by an ICU-monitored patient is complicated by severe
polymicrobial sepsis. By combining the two-hit model with
daily blood sampling, we were able to detect potential early
and late diﬀerences between surviving and dying septic
animals and follow the evolution of those changes prior
and/or after each of the hits.
Given that an extensive blood loss typically coincides
with injury and/or trauma, combining these two elements
into an initial challenge is more clinically relevant than
referring to established ﬁrst-hit models consisting solely of
hemorrhage [30]. Elimination of either trauma or hem-
orrhage component may signiﬁcantly distort the ensuing
pathophysiological immunoinﬂammatory response, and in
eﬀect produce incomplete or erroneous conclusions. The
growing awareness to the above-mentioned facts has pro-
voked attempts to develop more representative (two-hit)
animal models aimed at investigating the pathogenesis of
sepsis as the secondary insult.
Nosocomial (ventilator-associated) pneumonia is a ma-
jor cause of secondary septic complications in trauma
patients with prolonged ICU stays [31, 32]a l t h o u g hi n c i -
dences of polymicrobial sepsis are also reported [33]. An
abdominal focus of infection may be viewed as relatively
suboptimal given the prevalence of lung-associated sec-
ondary infections in polytrauma patients. In our model,
however, the cecal ligation and puncture primarily served
as a trigger to produce a severe polymicrobial challenge
(as opposed to the typically monobacterial lung-associated
sepsis) that spreads systemically in a protracted fashion,
rather than a model of abdominal peritonitis per se.M o r e -
over, our model was deliberately deprived of relevant
intangibles such as preexisting comorbidities (e.g., diabetes,
atherosclerosis) and operative interventions that are rou-
tinely observed/performed in patients and may signiﬁcantly
skew investigated parameters and outcome [34, 35]. We
chose to use healthy mice since any confounding factor
in addition to the two-hit challenge would likely generate
too much variability and make data interpretation diﬃcult.
The CLP challenge itself provides an adequate variability
regarding both the outcome and wide range of generated
responses. The level of sepsis-induced mortality in our
model (approx. 50% at day 5 post-CLP) was carefully set to
closely reproduce clinical data (reporting between 20% and
60% incidence of deaths in the septic ICU patients) [12].
This is important since data generated in highly lethal
CLP models might artiﬁcially enhance predictive value ofJournal of Biomedicine and Biotechnology 9
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Figure 8: Retrospective comparison of circulating glucose, AST, ALT, LDH, and urea in dying (DIE) versus surviving (SUR) animals after-
CLP. 3-month-oldfemale mice were subjected to trauma/hemorrhage followed by polymicrobial CLP-induced sepsis. Displayed values were
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DIE n = 14, SUR n = 23), 48h (DIE n = 19, SUR n = 34; AST: DIE n = 9, SUR n = 23), 72h (DIE n = 12, SUR n = 34; AST: DIE n = 3,
SUR n = 23), and 96h (SUR at least n = 33; AST: SUR n = 23) after-CLP. Dotted lines represent normal values. ∗P<. 05.10 Journal of Biomedicine and Biotechnology
some biomarkers [36]. For example, we noted a signiﬁcant
improvement in predictive accuracy for outcome of IL-6 in
severe (LD80) CLP model compared to a milder (LD30)C L P
injury (unpublished observation).
Both hemorrhage and trauma elements of the ﬁrst hit
were modiﬁed from our original protocol [19]: guillotine
was replaced with custom-built blunt pliers while the
hemorrhage step was initiated immediately after femur
fracture (versus a 2h delay in the previous setup), and
the hemorrhage volume was decreased by 20% (to 40% of
TBV). In our laboratory, the use of pliers better reproduced
blunt soft tissue damage while still providing an excellent
reproducibilityofnoncomminuted,midshaft femurfracture.
The hemorrhage modiﬁcations were dictated by both the
desire to reproduce a more clinically relevant timing and
to produce a survivable hypovolemic shock. Given that
in trauma patients fractures naturally diverge in terms of
location, type and severity of concurrent soft tissue injury
and extensive hemorrhage is frequently lethal, a relatively
rigorous standardization of these elements can be viewed
as the model’s shortcoming rather than advantage. Yet, in
this particular two-hit setup, a relatively similar magnitude
of the TH hit severity and maximal elimination of lethality
are desired, as we aimed to verify our model by studying
the outcome-dependent responses triggered by the CLP
hit (and not by the TH). Additionally, extrapolability of
potential responses indicative of the post-CLP outcome is
more relevant if such diverse reactions were produced by a
conservativelystandardized (hencegeneratingmore uniform
responses) TH hit. Finally, the adherence to the Russell-
Burch “3R” tenet (replace, reﬁne, reduce) should not be
overlooked [37].
Profound changes in the immunoinﬂammatory status
caused by trauma/hemorrhage, speciﬁcally those propagat-
ing development of progressive immunoparalysis, have been
postulated to be responsible for the increased susceptibility
to secondary sepsis [36]. Although, due to technical con-
straints, we were not able to determine the cytokine-based
immunoinﬂammatory status of TH-CLP mice, this aspect
requirescarefulevaluationinsubsequentexperiments. Given
that immuno-inﬂammatory ﬂuctuations frequently occur in
patients over the period of several hours, a rigorous and
continuous surveillance of the ICU patients’ immune status
is fundamental in ensuring the most adequate therapeutic
strategy (e.g., rapid adjustments of treatment to tailor it to
the ongoing shifts of the immune system). To enable such
tactics in our TH-CLP model, we subjected all mice to daily
low-volume blood sampling via facial vein puncture. This
technique provides daily collection of blood (20µL/mouse)
from critically ill mice with virtually no negative eﬀects
upon their outcome and/or health status [29]. Despite
a limited sample volume available for analysis, advanced
and highly sensitive techniques such as multiplex bead
assays and various automated biochemistry analyzers allow
accurate measurement of dozens of circulating biomarkers
and/or cell subpopulations. However, in the context of a
joint critical disease/repetitive sampling protocol, its main
advantage lies in an ability to investigate a natural evolution
of a given disease: any relevant immuno-inﬂammatory,
metabolic, and/ororgan function alterations can be followed
over time in individual subjects to an undeﬁned outcome.
This is in stark contrast to studies in which animals are
sacriﬁced at predeﬁned time points providing only a narrow
snapshot assessment of investigated endpoints/pathways
without option to match recorded changes with outcome.
In our study, we employed the TH-CLP/monitoring
combination to gain preliminary insight into outcome-
related mechanisms developing during the acute phase of
post-traumatic sepsis. In context of potential posttrau-
matic septic complications, the period between the ﬁrst
(trauma/hemorrhage) and the secondary (sepsis) challenge
may be as decisive as the immediate time span following
the onset of sepsis. If relevant risk-correlating marker(s)
are identiﬁed in the posttraumatic but preseptic phase,
one could identify not only subjects with high risk of
developing septic complications (posttrauma) but also those
who display higher risk of death once sepsis sets in. While
this model does not allow any insight into the ﬁrst scenario
(all mice undergo sepsis), it is well matched to investigate
the latter situation. We therefore performed outcome-based
retrospective analysis of all analysed parameters to detect
potential early (pre-CLP) and late (post-CLP) diﬀerences
between surviving and dying individuals. In the pre-CLP
phase, there was a much stronger post-TH (24h pre-CLP)
AST spike (indirectly indicative of hepatic injury) in mice
that died within ﬁrst few days after the onset of peritonitis
(compared to survivors), whereas the same cohort (DIE)
showed clear and profound metabolic/organ function dis-
turbances in the post-CLP period. Further detailed analysis
are needed to establish whether some post-TH mice develop
a more intense dysfunction of selected organs prior to sepsis
(consequentlypredisposing themforunfavourablepost-CLP
outcome) and how exactly organ disturbances drive lethal
septic responses both prior and after the onset of sepsis. In
any respect, such longitudinal assessments, enabled by more
ICU-like tailored models such as the one described above,
generate valuable ﬁndings that may be then successfully
extrapolated to respective clinical scenarios. This in turn
may help in identifying ideal time points and/or targets
for successful therapeutic interventions in sepsis and other
related critical diseases.
5.Conclusion
The modiﬁed and clinically relevant TH-CLP model allows
am o r ea d e q u a t ei n v e s t i g a t i v ei n s i g h ti n t ot h ec o u r s e
of (polymicrobial) septic complications following trauma.
Additional integration of the daily blood sampling into
the TH-CLP setup closely emulates one of the major
components of the ICU protocol: repetitive monitoring
of critically sick patients. The daily monitoring of TH-
CLP mice was a basis for outcome-based (retrospective)
stratiﬁcation of responses they generated during both two-
hit phases. Such an approach enables in turn correlation of
circulating cells/biomarkers to septic outcomes even prior to
the development of sepsis. If veriﬁed in a clinical setting,
ﬁndings from such advanced models not only could helpJournal of Biomedicine and Biotechnology 11
to categorize patients into high-and low-risk of death after
their traumatic insult gets complicated by sepsis, but also to
prevent the onset of septic sequelae altogether.
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